Literature DB >> 18633753

HOMA-estimated insulin resistance is associated with hypertension in Iranian diabetic and non-diabetic subjects.

Alireza Esteghamati1, Omid Khalilzadeh, Mehrshad Abbasi, Manouchehr Nakhjavani, Leila Novin, Abdul Reza Esteghamati.   

Abstract

The relationship between insulin resistance (IR) and essential hypertension (HTN) is controversial. The aim of this study was to determine the association of IR estimated by homeostasis model assessment of insulin resistance (HOMA-IR) and HTN in a large sample of Iranian diabetic and non-diabetic population. A total of 2047 diabetic and non-diabetic individuals with or without HTN, aged 30-75 yrs, who were referred to a university general hospital between November 2004 and April 2007 were included in this study. Demographic data and anthropometric characteristics of participants were recorded. Fasting blood samples were collected, and fasting plasma glucose (FPG), serum creatinine, lipids, insulin, C-peptide and HbA1c were measured. HOMA-IR and HOMA derived Beta-cell function (HOMA-B) were also calculated. Age, sex and waist girth adjusted HOMA-IR values were compared between hypertensive and normotensive subjects. Hypertensive patients had significantly higher HOMA-IR than age-, sex-, and waist girth-adjusted normotensive individuals in both non-diabetic (2.163 +/- 0.08 and 1.75 +/- 0.03, p < 0.001) and diabetic (3.40 +/- 0.10 and 3.07 +/- 0.09, p < 0.05) groups. Multivariate logistic regression analysis showed that after adjustment for age, sex, waist girth, BMI, triglyceride, total cholesterol, FPG, and C-peptide, HOMA-IR was a significant independent predictor of HTN in all subjects (odds ratio = 1.117, CI 95% = 1.026-1.216, p < 0.05) and in diabetic and non-diabetic subjects separately (odds ratio = 1.102, CI 95% = 1.009-1.203, p < 0.05 and odds ratio = 1.328, CI 95% = 1.116-1.580, p < 0.01, respectively). In conclusion, this study showed that IR is associated with HTN in Iranian diabetic and non-diabetic subjects.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18633753     DOI: 10.1080/10641960802269919

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  7 in total

1.  Insulin resistance explains the relationship between novel cardiovascular risk factors and hypertension. The Telde Study.

Authors:  A M Wägner; J C Wiebe; M Boronat; P Saavedra; D Marrero; F Varillas; F J Nóvoa
Journal:  J Endocrinol Invest       Date:  2010-10-27       Impact factor: 4.256

2.  Insulin resistance in Nigerians with essential hypertension.

Authors:  T O Akande; J O Adeleye; S Kadiri
Journal:  Afr Health Sci       Date:  2013-09       Impact factor: 0.927

3.  Hemoglobin A1c, body mass index, and the risk of hypertension in women.

Authors:  Kathryn A Britton; Aruna D Pradhan; J Michael Gaziano; JoAnn E Manson; Paul M Ridker; Julie E Buring; Howard D Sesso
Journal:  Am J Hypertens       Date:  2010-12-09       Impact factor: 2.689

4.  Comparison of Fasting Insulin Level, Homeostatic Model of Insulin Resistance, and Lipid Levels between Patients with Primary Hypertension and Normotensive Subjects.

Authors:  Rithvik Ramesh; Viswanathan Pandurangan; Sudha Madhavan; Devasena Srinivasan; Emmanuel Bhaskar; Lakshmi Marappa; Aiswarya M Nair; Vaasanthi Rajendran; Priyadarshini Varadaraj
Journal:  Rambam Maimonides Med J       Date:  2022-04-26

5.  Insulin resistance in transgender individuals correlates with android fat mass.

Authors:  Ingrid Bretherton; Cassandra Spanos; Shalem Y Leemaqz; Gehan Premaratne; Mathis Grossmann; Jeffrey D Zajac; Ada S Cheung
Journal:  Ther Adv Endocrinol Metab       Date:  2021-01-23       Impact factor: 3.565

6.  Cardiometabolic risk factors in young Indian men and their association with parameters of insulin resistance and beta-cell function.

Authors:  Yashdeep Gupta; Alpesh Goyal; Mani Kalaivani; Nikhil Tandon
Journal:  World J Cardiol       Date:  2022-08-26

7.  Association of hypertension and hypertriglyceridemia on incident hyperuricemia: an 8-year prospective cohort study.

Authors:  Yuan Zhang; Miaomiao Zhang; Xiawen Yu; Fengjiang Wei; Chen Chen; Kai Zhang; Shuzhi Feng; Yaogang Wang; Wei-Dong Li
Journal:  J Transl Med       Date:  2020-10-31       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.